The Engineering Single Domain Antibodies PhD Studentship 2026 at Imperial College London provides a fully funded doctoral research opportunity in protein engineering, molecular biology, and antibody design. The project focuses on developing next-generation therapeutic antibodies using experimental and computational techniques.
Imperial College London offers this studentship to train researchers in advanced biophysics, protein science, and biomedical engineering.
About the Engineering Single Domain Antibodies Studentship
The studentship supports a full-time PhD project in the Department of Chemical Engineering at Imperial College London.
The project:
- Awards 1 fully funded PhD position
- Starts in October 2026
- Combines experimental biology and computational analysis
The research focuses on engineering single-domain antibodies with improved stability, binding properties, and therapeutic potential. Students work in a multidisciplinary environment involving protein expression, purification, and biophysical characterization.
Applicants must contact the supervisor directly to apply.
Why Choose The Engineering Single Domain Antibodies Studentship?
This PhD studentship allows students to contribute to cutting-edge biomedical research that directly impacts drug discovery and therapeutic development.
At Imperial College London, researchers gain:
- Training in molecular biology and protein engineering
- Experience with computational protein design tools
- Access to world-class laboratories and equipment
- Collaboration across chemistry, biology, and engineering disciplines
The project prepares students for careers in biotechnology, pharmaceuticals, and academic research.
Engineering Single Domain Antibodies Studentship Summary
- Host Country: United Kingdom
- Host University: Imperial College London
- Scholarship Name: Engineering Single Domain Antibodies PhD Studentship
- Study Level: Doctoral (PhD)
- Funding Type: Fully funded
- Coverage Includes: Full PhD funding (tuition + stipend implied by studentship)
- Number of Awards: 1
- Department: Chemical Engineering
- Study Mode: Full-time
- Start Date: October 2026
- Eligible Applicants: Home fee-status students
- Application Method: Direct contact with supervisor
- Start Date: October 2026
- Selection Basis: Academic background, research interest, and suitability
Studentship Benefits
The Engineering Single-Domain Antibodies Studentship provides:
- Full PhD funding support
- Training in protein engineering and antibody design
- Access to advanced experimental and computational facilities
- Experience in biophysics, molecular biology, and data analysis
- Multidisciplinary supervision and mentoring
- Career preparation in biotechnology and pharmaceutical research
Eligibility Criteria
Applicants must meet the following requirements:
- Hold a strong background in molecular biology, protein science, or related fields
- Demonstrate interest in data analysis and computational biology
- Show willingness to learn basic programming skills
- Apply for a PhD in the Department of Chemical Engineering
- Not be a continuing Imperial PhD student
- Meet Imperial College London’s PhD admission standards
Required Documents
Applicants must prepare:
- PhD application materials (CV, transcripts, etc.)
- Academic degree certificates
- Research background summary
- Statement of interest
- Contact with supervisor ([email protected])
- Any additional documents requested by the research group
Application Process & Timeline
Follow these steps:
- Identify interest in the Single-Domain Antibodies PhD project.
- Contact the supervisor (Professor Pietro Sormanni) via email.
- Discuss research suitability and project alignment.
- Submit a PhD application to Imperial College London.
- Provide academic documents and research background.
- Be shortlisted based on academic and research fit.
- Receive the final selection decision from the department.
